Riskpilot← Back to searchSign inGet full accessAskersundstandläkarna AB
ABActiveOrg 5565200754Smedjegränd 3Dental practice care activities · NACE 8623Est. 199512 employees
Revenue 2025
SEK 15,1M
-2% vs 2024
EBITDA margin
10.1%
-24% vs 2024
Equity ratio
45.7%
Financial strength
Net profit 2025
SEK 1,4M
+8% vs 2024
| Revenue | SEK 15,1M | -2% |
| EBITDA | SEK 1,5M | -24% |
| Net profit | SEK 1,4M | +8% |
| Total assets | SEK 4,8M | -13% |
| Equity | SEK 2,2M | +24% |
| Employees | 12 | — |
Legal name
Askersundstandläkarna AB
Org number
5565200754
Legal form
Aktiebolag
NACE code
8623 · Dental practice care activities
Founded
14 juli 1995
Share capital
SEK 100 000
Employees
12 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall bedriva tandvård och kursverksamhet i anslutning härtill ävensom idka därmed förenlig verksamhet.
Address
Smedjegränd 3
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 12 751 | 12 665 | 13 407 | 15 450 | 15 131 |
| Staff expenses | — | — | — | — | −8 566 |
| EBITDA | 2 544 | 2 422 | 1 043 | 2 003 | 1 527 |
| Depreciation & amort. | −741 | −917 | −639 | −369 | −354 |
| EBIT | 1 803 | 1 505 | 404 | 1 634 | 1 173 |
| Net financials | 86 | 1 | 27 | 58 | 542 |
| Profit before tax | 3 299 | 2 526 | 431 | 1 692 | 1 715 |
| Tax | −736 | −554 | −87 | −384 | −296 |
| Net profit | 2 563 | 1 972 | 344 | 1 308 | 1 419 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 6 894 | 6 822 | 5 432 | 5 502 | 4 811 |
| Equity | 3 156 | 2 628 | 1 472 | 1 780 | 2 199 |
| Long-term debt | 0 | 0 | 0 | 0 | — |
| Short-term debt | 2 454 | 3 852 | 3 509 | 3 164 | 1 946 |
| Total debt | 2 454 | 3 852 | 3 509 | 3 164 | 1 946 |
EBITDA margin
10.1%
This company
15.8%
Market median
-36% vs market
20212025
Equity ratio
45.7%
This company
38.2%
Market median
+20% vs market
20212025
Return on equity
64.5%
This company
18.4%
Market median
+251% vs market
20212025
Net profit margin
9.4%
This company
8.1%
Market median
+16% vs market
20212025
Asset turnover
3.15×
This company
1.12×
Market median
+181% vs market
20212025
Debt / equity
1.19×
This company
0.62×
Market median
-92% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
CM | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
B&E Baecklund Invest AB
Askersundstandläkarna AB Board members of Askersundstandläkarna AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Claes Magnus Jonasson | Audit | 0 companies |
| Margareta Baecklund | Deputy Board Member | 0 companies |
| Anna Gisela Baecklund | Deputy Board Member | 0 companies |
| Erik Baecklund | Board of Directors | 0 companies |
| Astrid Bodil Gisela Baecklund | Chairman | 0 companies |